Juan Font - Cencora Senior Vice President - General Management
| COR Stock | USD 264.82 0.68 0.26% |
President
Mr. Juan A. Font is Senior Vice President General Management of the Company. Mr. Font has served as our Senior Vice President, General Management since March 2018. Mr. Font is responsible for maximizing revenue growth and return on invested capital across our portfolio. Mr. Font joined us in 2010 and has held positions of increasing responsibility, serving most recently as our Vice President of General Management. He brings over 15 years of experience in direct sales, business operations and finance in the data center and telecommunications industries. Prior to joining us, Mr. Font held direct sales contributor roles with Equinix, Inc., an owner and operator of data centers, covering strategic verticals. He also held roles of increasing responsibility in financial management and business operations across European markets with Teleglobe International Holdings Ltd., a provider of wholesale voice, data, IP and mobile signaling services. His previous experience also includes The World Bank Group, where he oversaw investments in the power sector since 2018.
| Age | 51 |
| Tenure | 7 years |
| Professional Marks | MBA |
| Address | 1 West First Avenue, Conshohocken, PA, United States, 19428-1800 |
| Phone | (610) 727-7000 |
| Web | https://www.cencora.com |
Juan Font Latest Insider Activity
Tracking and analyzing the buying and selling activities of Juan Font against Cencora stock is an integral part of due diligence when investing in Cencora. Juan Font insider activity provides valuable insight into whether Cencora is net buyers or sellers over its current business cycle. Note, Cencora insiders must abide by specific rules, including filing SEC forms every time they buy or sell Cencora'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Juan Font over two months ago Disposition of 469 shares by Juan Font of American Tower at 182.56 subject to Rule 16b-3 |
Cencora Management Efficiency
The company has Return on Asset of 0.0286 % which means that on every $100 spent on assets, it made $0.0286 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 1.9815 %, implying that it generated $1.9815 on every 100 dollars invested. Cencora's management efficiency ratios could be used to measure how well Cencora manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Cencora's Return On Tangible Assets are relatively stable compared to the past year. As of 03/19/2025, Return On Assets is likely to grow to 0.02, while Return On Capital Employed is likely to drop 0.15. At this time, Cencora's Return On Assets are relatively stable compared to the past year. As of 03/19/2025, Asset Turnover is likely to grow to 5.17, while Intangible Assets are likely to drop slightly above 2.7 B.Similar Executives
| Found 14 records | PRESIDENT Age | ||
| Stacey Kravitz | United Natural Foods | N/A | |
| Christopher Testa | United Natural Foods | 54 | |
| Paul Green | United Natural Foods | 62 | |
| Andre Persaud | United Natural Foods | 56 | |
| Joshua Dicker | Getty Realty | 60 | |
| Danion Fielding | Getty Realty | 47 | |
| Chris Finck | United Natural Foods | 56 | |
| Giorgio Tarditi | United Natural Foods | 52 | |
| Bob Garibaldi | United Natural Foods | N/A | |
| Heather Kaminetsky | MYT Netherlands Parent | N/A | |
| Brian Dickman | Getty Realty | 49 | |
| Danielle Benedict | United Natural Foods | 52 | |
| Mark Olear | Getty Realty | 61 | |
| Thomas Pluta | Tradeweb Markets | 57 | |
Management Performance
| Return On Equity | 1.98 | ||||
| Return On Asset | 0.0286 |
Cencora Leadership Team
Elected by the shareholders, the Cencora's board of directors comprises two types of representatives: Cencora inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Cencora. The board's role is to monitor Cencora's management team and ensure that shareholders' interests are well served. Cencora's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Cencora's outside directors are responsible for providing unbiased perspectives on the board's policies.
| PharmD Mauch, CEO, President | ||
| Michael Millegan, Independent Director | ||
| James Cleary, Executive CFO | ||
| Elizabeth JD, Executive Officer | ||
| Bennett Murphy, Senior Relations | ||
| Maile Kaiser, Senior Vice President of Sales | ||
| John Chou, Ex CEO | ||
| Jim Adkins, Vice Services | ||
| Pawan Verma, Executive Officer | ||
| Jeffrey Finnin, Chief Financial Officer | ||
| Derek McCandless, Senior Vice President - Legal, General Counsel, Secretary | ||
| David Wilson, Lead Independent Director | ||
| Elizabeth Campbell, Executive Officer | ||
| Silvana Battaglia, Executive Officer | ||
| Leslie Donato, Executive Officer | ||
| Lazarus Krikorian, Chief VP | ||
| Franois Mandeville, Executive Officer | ||
| Juan Guerra, EVP Group | ||
| Robert Stuckey, Independent Chairman of the Board | ||
| J Quinn, VP Treasurer | ||
| James Attwood, Independent Director | ||
| John Thompson, Independent Director | ||
| Aleksandra Krusko, Senior Vice President Information Technology | ||
| Steven Collis, President Chairman | ||
| Anthony Hatzenbuehler, Senior Vice President Data Center Operations | ||
| Jean Bua, Independent Director | ||
| Michael Koehler, Independent Director | ||
| Paul Szurek, President, Chief Executive Officer, Director | ||
| Ann Anaya, Senior Officer | ||
| Richard Tremonte, EVP Pharmaceuticals | ||
| Gina Clark, Executive Officer | ||
| Juan Font, Senior Vice President - General Management | ||
| Jennifer Dubas, Senior Officer | ||
| Brian Warren, Senior Vice President - Development and Product Engineering | ||
| Kelly Chambliss, Independent Director | ||
| Kathy Gaddes, Ex Officer | ||
| Patricia Higgins, Independent Director | ||
| Kourosh JD, Group VP | ||
| Steven Smith, Sr. VP of Sales and Marketing | ||
| RPh Nightengale, President Pharmacy |
Cencora Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Cencora a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 1.98 | ||||
| Return On Asset | 0.0286 | ||||
| Profit Margin | 0 % | ||||
| Operating Margin | 0.01 % | ||||
| Current Valuation | 54.92 B | ||||
| Shares Outstanding | 193.71 M | ||||
| Shares Owned By Insiders | 6.85 % | ||||
| Shares Owned By Institutions | 92.62 % | ||||
| Number Of Shares Shorted | 6.94 M | ||||
| Price To Earning | 82.16 X |
Pair Trading with Cencora
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Cencora position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cencora will appreciate offsetting losses from the drop in the long position's value.Moving together with Cencora Stock
Moving against Cencora Stock
| 0.85 | OM | Outset Medical | PairCorr |
| 0.77 | ELAB | Elevai Labs, Common Upward Rally | PairCorr |
| 0.73 | EMBC | Embecta Corp | PairCorr |
| 0.68 | EUDA | EUDA Health Holdings | PairCorr |
| 0.68 | FIGS | Figs Inc | PairCorr |
The ability to find closely correlated positions to Cencora could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Cencora when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Cencora - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Cencora to buy it.
The correlation of Cencora is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Cencora moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Cencora moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Cencora can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Cencora Stock Analysis
When running Cencora's price analysis, check to measure Cencora's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cencora is operating at the current time. Most of Cencora's value examination focuses on studying past and present price action to predict the probability of Cencora's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cencora's price. Additionally, you may evaluate how the addition of Cencora to your portfolios can decrease your overall portfolio volatility.